Colgate-Palmolive Company CL
86.06
0.74
0.87%
as of 25 Sep
- Market cap
- $68.3B
- P/E
- 33.9×
Follow CL
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
36.09 | 32.91 | 30.05 | 22.27 |
+8 more quarters Free account |
P/S ratio |
3.48 | 3.29 | 3.14 | 3.21 | |
P/FCF ratio |
19.00 | 18.15 | 17.58 | 18.76 | |
P/Operating CF |
73.66 | 91.54 | 43.98 | 51.21 | |
P/B ratio |
129.49 | 140.70 | 175.08 | 52.16 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
3.79 | 3.61 | 3.46 | 3.57 | |
EV/EBITDA |
17.01 | 15.79 | 14.54 | 14.68 | |
EV/Operating CF |
17.90 | 17.27 | 16.82 | 17.87 | |
EV/FCF |
20.68 | 19.91 | 19.43 | 20.83 | |
Quick Ratio |
0.54 | 0.54 | 0.43 | 0.48 | |
Current Ratio |
1.03 | 1.02 | 0.83 | 0.93 | |
Net Debt/EBITDA |
5.54 | 5.93 | 5.66 | 5.87 | |
Debt/Assets |
46.80% | 48.00% | 48.92% | 48.07% | |
Debt/Equity |
13.88 | 16.41 | 21.88 | 6.80 | |
Asset Turnover |
1.23 | 1.25 | 1.26 | 1.17 | |
Operating CF/Net income |
1.44 | 1.16 | (40.36) | 1.72 | |
Capex/Depreciation |
(0.83) | (0.88) | (0.16) | (0.98) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
39.73% | 38.99% | 39.60% | 38.41% | |
Intangible Assets out of Total Assets |
0.27 | 0.28 | 0.29 | 0.32 | |
Share Based Compensation of Revenue |
0.71% | 0.75% | 0.54% | 1.40% | |
Graham Net Nets |
(0.14) | (0.15) | (0.16) | (0.16) | |
Graham Number |
6.36 | 5.94 | 5.17 | 11.13 | |
Earnings Yield |
2.77% | 3.04% | 3.33% | 4.49% | |
Free Cash Flow Yield |
5.26% | 5.51% | 5.69% | 5.33% | |
Revenue per Share |
6.71 | 6.64 | 6.47 | 6.35 | |
Operating CF per Share |
1.24 | 0.93 | 1.80 | 1.56 | |
Capex per Share |
(0.16) | (0.17) | (0.22) | (0.19) | |
Free Cash Flow per Share |
1.08 | 0.76 | 1.58 | 1.37 | |
Cash per Share |
1.71 | 1.66 | 1.59 | 1.58 | |
Shareholders Equity per Share |
0.71 | 0.61 | 0.45 | 1.53 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.71 | 0.61 | 0.45 | 1.53 | |
Free Cash Flow |
867.00 | 609.00 | 1,276.00 | 1,106.00 | |
Working Capital |
160.00 | 148.00 | (1,144.00) | (457.00) | |
Capital Expenditures |
(128.00) | (138.00) | (177.00) | (155.00) | |
Net Current Asset Value |
(9,916.00) | (10,042.00) | (10,256.00) | (10,236.00) | |
EV/EBIT |
25.49 | 23.49 | 21.36 | 16.76 | |
Capex to Sales |
0.02 | 0.03 | 0.03 | 0.03 | |
Net Profit Margin |
12.93% | 12.13% | (0.69%) | 14.32% | |
Price to Operating Income |
23.42 | 21.41 | 19.33 | 15.09 | |
| Other line items | |||||
Average Receivables |
1,867.50 | 1,807.00 | 1,598.00 | 1,759.50 | |
Average Payables |
1,952.50 | 1,948.00 | 1,947.00 | 1,745.50 | |
Average Inventory |
2,150.50 | 2,105.50 | 2,009.50 | 2,075.00 | |
Average Assets |
17,130.00 | 16,628.50 | 16,188.00 | 17,143.50 | |
Average Common Equity |
809.00 | 609.50 | 454.50 | 1,037.00 |
Columns are period end dates